Lesson plan

Flemming Ørnskov

Flemming Ørnskov (born 24 January 1958) is a Danish businessman. He has been the chief executive officer (CEO) of Galderma since October 2019. He was previously the CEO of Shire plc, a FTSE 100 specialty biopharmaceutical company as of 30 April 2013, succeeding Angus Russel. He previously worked for Bayer, Bausch & Lomb and Novartis. He is also the non-executive chairman of Waters Corporation, a position he's been holding since 2017. Ørnskov was educated at the . He received his MD from the University of Copenhagen, followed by an MBA from INSEAD, and a Master of Public Health (MPH) from Harvard University. Ørnskov is qualified as a doctor in Denmark and has experience as a practicing hospital physician. Ørnskov led Galderma's IPO on the Zurich stock exchange on March 22, 2024, one of the biggest offerings in Europe in years and the biggest in Switzerland since 2017. He declares Galderma plans to use the proceeds to pay down debt and invest in its pipeline. Ørnskov is married to a German management consultant, with whom he has two sons. He has one son and a daughter from a previous marriage.

Back to article

Article summary

Flemming Ørnskov (born 24 January 1958) is a Danish businessman. He has been the chief executive officer (CEO) of Galderma since October 2019. He was previously the CEO of Shire plc, a FTSE 100 specialty biopharmaceutical company as of 30 April 2013, succeeding Angus Russel. He previously worked for Bayer, Bausch & Lomb and Novartis. He is also the non-executive chairman of Waters Corporation, a position he's been holding since 2017. Ørnskov was educated at the . He received his MD from the University of Copenhagen, followed by an MBA from INSEAD, and a Master of Public Health (MPH) from Harvard University. Ørnskov is qualified as a doctor in Denmark and has experience as a practicing hospital physician. Ørnskov led Galderma's IPO on the Zurich stock exchange on March 22, 2024, one of the biggest offerings in Europe in years and the biggest in Switzerland since 2017. He declares Galderma plans to use the proceeds to pay down debt and invest in its pipeline. Ørnskov is married to a German management consultant, with whom he has two sons. He has one son and a daughter from a previous marriage.

Key claims

  1. date of birth: 1958-01-24 — source: Wikipedia, revision 1372548380, retrieved 2026-10-20 · confidence 0.95

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. The record states that the date of birth is "1958-01-24". What evidence would count against this claim?
  3. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  4. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.